Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record.

Association of Race and Gender With HIV-1 RNA Levels and Immunologic Progression

Anastos, Kathryn, Gange, Stephen J., Lau, Bryan, Weiser, Barbara, Detels, Roger, Giorgi, Janis V., Margolick, Joseph B., Cohen, Mardge, Phair, John, Melnick, Sandra, Rinaldo, Charles R., Kovacs, Andrea, Levine, Alexandra, Landesman, Sheldon, Young, Mary, Muñoz, Alvaro, Greenblatt, Ruth M.·2000·Journal of Acquired Immune Deficiency Syndromes

Abstract

CONTEXT: HIV-1 RNA and lymphocyte subset levels are the principal indications for antiretroviral treatment. Past reports have differed with regard to the effect of gender and race on these measures and in measures of disease progression. OBJECTIVE: To assess racial and gender differences in HIV-1 RNA levels and CD4+ lymphocyte decline. DESIGN: A longitudinal study based in the two largest HIV natural history cohort studies conducted in 7 metropolitan areas of the United States. RESULTS: In all, 1256 adult women and 1603 adult men for whom multiple data points were available prior to initiation of antiretroviral therapy were included. Women were more likely to be nonwhite, to have a history of injection drug use, and to have HIV-associated symptoms. After adjustment for differences in measurement method, baseline CD4+ cell count, age, and clinical symptoms, HIV-1 RNA levels were 32% to 50% lower in women than in men at CD4+ counts >200 cells/mm3 (p <.001) but not at CD4+ cell counts <200 cells/mm3. HIV-1 RNA levels were also 41% lower in nonwhites than in whites (p <.001) and 21% lower in persons reporting a prior history of injection drug use (p <.001). Women had more rapid declines in CD4+ cell counts over time than men (difference in slope of 46 cells/year) and nonwhite individuals had slower decline in CD4 cell counts than whites (difference of 39 cells/year). CONCLUSIONS: Both race and gender influence the values of HIV-1 RNA and the rate of HIV-1 disease progression as indicated by decline in CD4 cell counts over time. These effects could provide clues regarding the factors that influence HIV-disease progression and may indicate that guidelines for therapy should be adjusted for demographic characteristics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00042560-200007010-00004

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 177

Metadata

Authors
Anastos, K., Gange, S. J., Lau, B., Weiser, B., Detels, R., Giorgi, J. V., Margolick, J. B., Cohen, M., Phair, J., Melnick, S., Rinaldo, C. R., Kovacs, A., Levine, A., Landesman, S., Young, M., Muñoz, A., & Greenblatt, R. M.
Venue
Journal of Acquired Immune Deficiency Syndromes
Published
2000-07
Volume
24
Issue
3
Pages
218-226
ISSN
1525-4135 (ISSN-L)
OpenAlex
W1993811071
Cited by
177
References
0
FWCI
3.30
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of Race and Gender With HIV-1 RNA Levels and Immunologic Progression. https://app.cochat.ai/papers/10.1097/00042560-200007010-00004
The paper
Anastos, K., Gange, S. J., Lau, B., Weiser, B., Detels, R., Giorgi, J. V., Margolick, J. B., Cohen, M., Phair, J., Melnick, S., Rinaldo, C. R., Kovacs, A., Levine, A., Landesman, S., Young, M., Muñoz, A., & Greenblatt, R. M. (2000). Association of Race and Gender With HIV-1 RNA Levels and Immunologic Progression. Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00042560-200007010-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.